Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease

J Alzheimers Dis. 2023;96(1):41-45. doi: 10.3233/JAD-230953.

Abstract

Familial Alzheimer's disease (fAD) mutations in the amyloid-β protein precursor (AβPP) enhance brain AβPP C-Terminal Fragment (CTF) levels to inhibit lysosomal v-ATPase. Consequent disrupted acidification of the endolysosomal pathway may trigger brain iron deficiencies and mitochondrial dysfunction. The iron responsive element (IRE) in the 5'Untranslated-region of AβPP mRNA should be factored into this cycle where reduced bioavailable Fe-II would decrease IRE-dependent AβPP translation and levels of APP-CTFβ in a cycle to adaptively restore iron homeostasis while increases of transferrin-receptors is evident. In healthy younger individuals, Fe-dependent translational modulation of AβPP is part of the neuroprotective function of sAβPPα with its role in iron transport.

Keywords: 5’Untranslated region; Alzheimer’s disease; C-terminal fragments; amyloid-β protein precursor; iron; iron homeostasis; iron regulatory protein; iron responsive element; lysosomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Protein Precursor / genetics
  • Amyloid beta-Protein Precursor / metabolism
  • Humans
  • Iron / metabolism
  • Lysosomes / metabolism
  • Protein Biosynthesis

Substances

  • Iron
  • Amyloid beta-Protein Precursor
  • Amyloid beta-Peptides